Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

AbbVie Inc. (NYSE:ABBV)

Analysis of Liquidity Ratios

Beginner level

Liquidity Ratios (Summary)

AbbVie Inc., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Current ratio 0.84 3.18 0.98 1.28 1.65
Quick ratio 0.60 2.91 0.78 0.89 1.14
Cash ratio 0.30 2.56 0.47 0.59 0.66

Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. AbbVie Inc.’s current ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. AbbVie Inc.’s quick ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. AbbVie Inc.’s cash ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Current Ratio

AbbVie Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Current assets 24,173  49,519  16,945  21,223  16,187 
Current liabilities 28,661  15,585  17,239  16,641  9,781 
Liquidity Ratio
Current ratio1 0.84 3.18 0.98 1.28 1.65
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.72 1.44 1.62 2.26 4.02
Amgen Inc. 1.81 1.44 2.79 5.49 4.11
Bristol-Myers Squibb Co. 1.58 1.60 1.61 1.55 1.55
Eli Lilly & Co. 1.40 1.16 1.73 1.32 1.37
Gilead Sciences Inc. 1.40 3.10 3.38 2.74 2.22
Illumina Inc. 3.60 6.69 2.49 3.99 3.29
Johnson & Johnson 1.21 1.26 1.47 1.41 2.47
Merck & Co. Inc. 1.02 1.24 1.17 1.33 1.78
Pfizer Inc. 1.35 0.88 1.57 1.35 1.25
Regeneron Pharmaceuticals Inc. 3.63 3.67 4.47 3.82 2.56
Vertex Pharmaceuticals Inc. 4.33 3.61 3.43 3.28 2.31
Zoetis Inc. 3.05 2.63 3.60 3.85 3.03
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.37 1.57 1.73 1.82 2.10
Current Ratio, Industry
Health Care 1.33 1.49 1.52 1.61 1.75

Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Current ratio = Current assets ÷ Current liabilities
= 24,173 ÷ 28,661 = 0.84

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. AbbVie Inc.’s current ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Quick Ratio

AbbVie Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Cash and equivalents 8,449  39,924  7,289  9,303  5,100 
Short-term investments 30  —  772  486  1,323 
Accounts receivable, net 8,822  5,428  5,384  5,088  4,758 
Total quick assets 17,301  45,352  13,445  14,877  11,181 
 
Current liabilities 28,661  15,585  17,239  16,641  9,781 
Liquidity Ratio
Quick ratio1 0.60 2.91 0.78 0.89 1.14
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.14 0.88 1.03 1.67 3.31
Amgen Inc. 1.30 1.01 2.44 4.98 3.68
Bristol-Myers Squibb Co. 1.28 1.26 1.37 1.30 1.27
Eli Lilly & Co. 0.85 0.68 1.20 0.91 0.98
Gilead Sciences Inc. 1.08 2.86 3.15 2.52 1.78
Illumina Inc. 3.18 6.00 2.23 3.43 2.75
Johnson & Johnson 0.91 0.94 1.08 1.04 2.04
Merck & Co. Inc. 0.58 0.78 0.72 0.83 1.24
Pfizer Inc. 0.78 0.50 0.84 0.93 0.84
Regeneron Pharmaceuticals Inc. 2.86 2.81 3.50 2.98 2.13
Vertex Pharmaceuticals Inc. 4.02 3.33 3.19 2.94 2.06
Zoetis Inc. 2.13 1.67 2.24 2.34 1.47
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 0.96 1.18 1.28 1.41 1.64
Quick Ratio, Industry
Health Care 0.95 1.13 1.12 1.24 1.35

Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 17,301 ÷ 28,661 = 0.60

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. AbbVie Inc.’s quick ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Cash Ratio

AbbVie Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Cash and equivalents 8,449  39,924  7,289  9,303  5,100 
Short-term investments 30  —  772  486  1,323 
Total cash assets 8,479  39,924  8,061  9,789  6,423 
 
Current liabilities 28,661  15,585  17,239  16,641  9,781 
Liquidity Ratio
Cash ratio1 0.30 2.56 0.47 0.59 0.66
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.60 0.38 0.45 1.08 2.82
Amgen Inc. 0.91 0.69 2.17 4.62 3.40
Bristol-Myers Squibb Co. 0.83 0.84 0.83 0.71 0.72
Eli Lilly & Co. 0.29 0.21 0.68 0.55 0.55
Gilead Sciences Inc. 0.65 2.50 2.84 2.19 1.29
Illumina Inc. 2.79 5.13 1.95 2.88 2.21
Johnson & Johnson 0.59 0.54 0.63 0.60 1.59
Merck & Co. Inc. 0.30 0.47 0.40 0.46 0.83
Pfizer Inc. 0.47 0.26 0.59 0.66 0.57
Regeneron Pharmaceuticals Inc. 1.33 1.53 1.95 1.24 0.84
Vertex Pharmaceuticals Inc. 3.55 2.85 2.83 2.59 1.81
Zoetis Inc. 1.66 1.07 1.39 1.43 0.65
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.58 0.81 0.90 1.01 1.23
Cash Ratio, Industry
Health Care 0.56 0.73 0.72 0.85 0.94

Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 8,479 ÷ 28,661 = 0.30

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. AbbVie Inc.’s cash ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.